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Sir
In a combined analysis of the Nurses’ Health Study and the Health
Professional Follow-up Study, on a total of 206 women and 143
men with cancer of the pancreas, Schernhammer et al (2002) did
not find an increased risk of pancreatic cancer in relation to
history of gallstones or cholecystectomy after adjusting for
potential confounding factors. The issue of a possible association
between gallstones or cholecystectomy and cancer of the pancreas
is, however, still open to discussion, because several investigations
reported an excess pancreatic risk in patients with gallstones.
Apart from the papers quoted in Schernhammer et al (2002),
some excess risks were found in cohort studies from the United
States (Bansal and Sonnenberg, 1996), Denmark (Johansen et al,
1996), and Sweden (Ye et al, 2001), and case–control studies
from the United Kingdom (Cuzick and Babiker, 1989), Greece
(Kalapothaki et al, 1993), and Israel (Schattner et al, 1997). The
strength of the association, however, was variable across studies,
and different potential confounding factors were not always taken
into account.
In order to provide further information on the issue, we updated
the analysis of a case–control study conducted in Italy between
1983 and 1992 (La Vecchia et al, 1990). Briefly, the study included
362 patients from the major teaching and general hospitals in
Greater Milan with incident, histologically confirmed pancreatic
cancer (229 men, 133 women, median age 59 years), and 1552
controls (1141 men, 411 women, median age 55 years) admitted to
the same network of hospitals for acute, non-neoplastic conditions,
unrelated to alcohol or tobacco consumption (33% traumas, 17%
nontraumatic orthopedic conditions, 36% acute surgical diseases,
and 14% other miscellaneous disorders). Less than 3% of cases and
controls approached refused the interview.
Trained interviewers identified and questioned cases and
controls using a structured questionnaire, including information
on education and other socioeconomic factors, anthropometric
measures, general lifestyle habits, such as tobacco and alcohol
consumption, and a few selected indicator foods. The patients were
also asked if they had a diagnosis of selected medical conditions,
and the age at first diagnosis was recorded.
Odds ratios (OR) and corresponding 95% confidence intervals
(CI) were estimated using unconditional multiple logistic regres-
sion models, including terms for age, education, tobacco
consumption, body mass index, and history of diabetes.
Table 1 gives the distribution of pancreatic cancer cases and
controls, and the corresponding ORs, according to history of
cholelithiasis. Subjects with a history of cholelithiasis showed no
increased risk of cancer of the pancreas (OR¼1.03, 95%
CI¼0.67–1.59). The OR was 1.33 (95% CI¼0.74–2.40) for
subjects with a diagnosis of cholelithiasis less than 10 years before
interview, and 0.80 (95% CI¼0.43–1.50) for diagnosis 10 or more
years before.
Thus, our findings are consistent with those of the Nurses’
Health Study and the Health Professional Follow-up Studies
(Schernhammer et al, 2002), and indicate that cholelithiasis is
not materially associated with pancreatic cancer risk after major
identified confounding factors have been considered. A modestly
increased risk was observed 10 years after a diagnosis of
cholelithiasis, but no greater excess risk can be found 10 or more
years after. Thus, if any association exists, it is unlikely to be
causal. The apparent association reported from several case–
control studies can at least in part be because of a more accurate
recall of gallbladder disease by pancreatic cancer patients. In
our study, however, information on medical history proved
satisfactorily reproducible (Bosetti et al, 2001), indicating that
recall bias is unlikely to have played a major role. Other potential
biases of this study should be limited, given the almost complete
response rate, the administration of a standard questionnaire
under similar conditions, and the same catchment area for cases
and controls.
Table 1 Relation between pancreatic cancer and history of cholelithiasis
among 362 cases and 1552 controls (Milan, Italy, 1983–1992)
Cases Controls OR
a (95% CI)
History of cholelithiasis
No 330 1430 1
b
Yes 32 122 1.03 (0.67–1.59)
Time since diagnosis
c (years)
o10 18 54 1.33 (0.74–2.40)
X10 14 67 0.80 (0.43–1.50)
aEstimates from unconditional logistic regression models, including terms for age, sex,
education, tobacco consumption, body mass index, and history of diabetes.
bReference category. *Correspondence: C Bosetti; E-mail: bosetti@marionegri.it
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